R529 Pill: brown, oval, 12mm
The pill with imprint R529 (Brown, Oval, 12mm) has been identified as Divalproex Sodium Delayed-Release 125 mg and is used for Bipolar Disorder, Mania, Migraine Prevention, Seizures, and Epilepsy. It belongs to the drug class fatty acid derivative anticonvulsants and is not a controlled substance.
Images for R529
Divalproex Sodium Delayed-Release
- Imprint
- R529
- Strength
- 125 mg
- Color
- Brown
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC)
- 55111-0529
- Inactive Ingredients
-
acetone,
hypromelloses,
hypromellose phthalate (31% phthalate, 40 cst),
isopropyl alcohol,
methylene chloride,
microcrystalline cellulose,
povidone,
corn starch,
silicon dioxide,
magnesium silicate,
titanium dioxide,
vanillin,
shellac,
ferrosoferric oxide,
butyl alcohol,
soya lecithin
Note: Inactive ingredients may vary.
Related images for "R529"
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (514)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.